|
Sign up now — watch Dec 10 No images? Click here ENDPOINTS at #ASH25Wednesday, December 10, 2025 | 11:30 AM – 1:00 PM ET The pressure is on as the hematology sector heads into ASH. Drug developers and investors are watching closely for data that could reshape R&D strategies and capital allocation across the blood disorder space at a time when the sector is navigating both breakthrough science and skeptical markets. Join us for insightful analysis from leading experts who'll break down what these results really mean for the industry. Reserve your spot now. |